Speakers

Rayaz Ahmed Malik

Place of Birth : UK
Born : 1964
Position : Professor of Medicine, Weill Cornell Medicine-Qatar, Qatar
Field of study : Diabetes and endocrine disorders, Diabetic microvascular disease and neuropathy
H. Index : 55

Rayaz Malik graduated in Medicine from the University of Aberdeen in 1991, obtained his MRCP (London) in 1996, Ph.D. from the University of Manchester in 1997 and was elected to become a fellow of the Royal College of Physicians in 2007. He was appointed as Consultant Physician and Senior Lecturer in 2001 and as Professor of Medicine and Consultant Physician in 2008 in Central Manchester University Teaching Hospitals and the University of Manchester. In 2014 he was appointed as Professor of Medicine at Weill Cornell Medicine and remains an honorary Professor of Medicine at the University of Manchester and Visiting Professor of Medicine at Manchester Metropolitan University. He was appointed as the Organizational Official on November 2016 and as the Assistant Dean for Clinical Research at Weill Cornell Medicine-Qatar in February 2019.

His research focuses on the pathogenesis, assessment, and treatment of diabetic and other peripheral neuropathies and central neurodegenerative disorders. The research is funded by the NIH, JDRF, QF, ECTRIMS, and MJFF. Over ~20 years he has pioneered the use of corneal confocal microscopy, a non-invasive ophthalmic instrument, to quantify diabetic and other peripheral neuropathies and more recently used CCM to assess neuronal damage in patients with Multiple Sclerosis, Parkinson’s disease, Stroke, Dementia, and Autism.

He was the President of Neurodiab (the diabetic neuropathy study group of the EASD) from 2009-2012. He is an associate editor for Diabetic Medicine (2006 to present); Journal of Diabetes and its Complications (2012-present), PLOS One (2016-present), BMC Neurology (2009-present) and Scientific Reports (2019-present).

• The focus of his clinical research is the diagnosis and management of neurodegenerative disease.

• He has pioneered the use of corneal confocal microscopy as a surrogate end point in diabetic neuropathy and other peripheral neuropathies as well as Parkinson’s disease, Multiple Sclerosis, Dementia, and Stroke.

• He has undertaken experimental and translational clinical studies/trials in diabetic neuropathy.

• PubMed Search to 2019: 282 papers

• Young Clinical Investigator Prize (Neurodiab/ EASD), 1999; Manchester Medical Society Prize, 2000; North East England Goulder Prize Lecture, 2012; ARC 14 Health Research Excellence Award (1st Prize), 2014; Camillo Golgi Prize (EASD), 2019;

• Chairman of Neurodiab (diabetic neuropathy study group of the EASD), 2010-2013

• House Physician and Surgeon, Aberdeen Royal Infirmary, UK (1991-1992)

• Registrar, Professorial Medical Unit, Manchester Royal Infirmary UK (1992-1994)

• Clinical Research Fellow with Prof AJM Boulton, Manchester, UK (1994-1995)

• Clinical Lecturer, University of Manchester, Senior Registrar, Manchester Royal Infirmary, UK (1995-2001)

• Senior Lecturer Consultant Physician, Manchester Royal Infirmary (2001-2008)

• Professor of Medicine, Manchester Royal Infirmary & University of Manchester (2008- 2014)

• Professor of Medicine, Weill Cornell Medicine-Qatar and New York & Honorary Professor of Medicine University of Manchester and Manchester Metropolitan University (2014- present)

• Associate Editor for Advances in Therapy (2009-present)

• JDRF Medical and Research Committee grant reviewer (2005-present)

• NIH (NIDDK) study section reviewer (2011-2013)

• Curriculum committee of the Manchester University School of Medicine (2006-2014)

• Progress committee of the Manchester University School of Medicine (2006-2014)

• Interview committee for the Manchester University School of Medicine (2006-2014)

• MSRA committee WCMC-Q (2014-present)

• JIRB committee WCMC-Q/HMC (2014-2015)